"
Team:Paris/Addressing overview2
From 2009.igem.org
(Difference between revisions)
Christophe.R (Talk | contribs) (→Adressing the message in the outer membrane : Overview) |
Christophe.R (Talk | contribs) (→OmpA) |
||
| (29 intermediate revisions not shown) | |||
| Line 2: | Line 2: | ||
{{Template:Paris2009}} | {{Template:Paris2009}} | ||
{{Template:Paris2009_menu3}} | {{Template:Paris2009_menu3}} | ||
| - | |||
| + | |||
| + | ==Addressing the message in the outer membrane : Main== | ||
<html> | <html> | ||
<style type="text/css"> | <style type="text/css"> | ||
| Line 37: | Line 38: | ||
padding-top: 7px; | padding-top: 7px; | ||
top: 0px; | top: 0px; | ||
| - | left: | + | left: 530px; |
background: url(https://static.igem.org/mediawiki/2009/4/40/Right_menu_paris.png); | background: url(https://static.igem.org/mediawiki/2009/4/40/Right_menu_paris.png); | ||
z-index:4; | z-index:4; | ||
| Line 65: | Line 66: | ||
<div id="right-side"></div> | <div id="right-side"></div> | ||
</html> | </html> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
Bacterial pathogens display proteins on their surface that may interact with their hosts in order to mount successful infections. Although the primary function of the peptidoglycan is to provide a physical barrier for protection against both mechanical and osmotic stresses, it also serves as a scaffold to anchor external structures such as the outer cell membrane in ''Escherichia Coli''. Over the past 20 years, it has become apparent that Gram-negative bacteria have evolved a variety of mechanism by which proteins are displayed on the cell surface (Tat and Sec transporter for example, cf the section "to the periplasm, export system" for more information about them). | Bacterial pathogens display proteins on their surface that may interact with their hosts in order to mount successful infections. Although the primary function of the peptidoglycan is to provide a physical barrier for protection against both mechanical and osmotic stresses, it also serves as a scaffold to anchor external structures such as the outer cell membrane in ''Escherichia Coli''. Over the past 20 years, it has become apparent that Gram-negative bacteria have evolved a variety of mechanism by which proteins are displayed on the cell surface (Tat and Sec transporter for example, cf the section "to the periplasm, export system" for more information about them). | ||
| Line 85: | Line 72: | ||
| - | + | <span/ id="1"> | |
| - | + | ===ClyA=== | |
| Line 92: | Line 79: | ||
Pore-forming toxins (PFTs) are a class of potent virulence factors that convert from a soluble form to a membrane-integrated pore. They exhibit their toxic effect either by destruction of the membrane permeability barrier or by delivery of toxic components through the pores. | Pore-forming toxins (PFTs) are a class of potent virulence factors that convert from a soluble form to a membrane-integrated pore. They exhibit their toxic effect either by destruction of the membrane permeability barrier or by delivery of toxic components through the pores. | ||
| - | Cytolysin A (ClyA, also known as HlyE), a PFT, is a cytolytic α-helical toxin responsible for the haemolytic phenotype of several | + | Cytolysin A (ClyA, also known as HlyE), a PFT, is a cytolytic α-helical toxin responsible for the haemolytic phenotype of several ''E. coli''. <sup>[[Team:Paris/Addressing_overview2#References|[1]]]</sup>. |
| Line 98: | Line 85: | ||
Why did we decided to use ClyA? | Why did we decided to use ClyA? | ||
| - | Althought the toxic effect of Cly A, using it is an interesting way to adress protein to the external membrane, because ClyA contain the signal peptide required to be exported form the cytoplasm to the outer membrane. In addition, it has been shown that certain membrane and/or soluble periplasmic proteins are enriched in vesicles while others are preferentially excluded. The majority of these enriched proteins happen to be virulence factors including cytolysin A of '' | + | Althought the toxic effect of Cly A, using it is an interesting way to adress protein to the external membrane, because ClyA contain the signal peptide required to be exported form the cytoplasm to the outer membrane. In addition, it has been shown that certain membrane and/or soluble periplasmic proteins are enriched in vesicles while others are preferentially excluded. The majority of these enriched proteins happen to be virulence factors including cytolysin A of ''E. coli'' <sup>[[Team:Paris/Addressing_overview2#References|[2]]]</sup>.. |
| - | Previous studies demonstrated that genetic fusions between ClyA of ''E. coli'' and reporter proteins such as Bla and GFP were translocated across the cytoplasmic membrane | + | Previous studies demonstrated that genetic fusions between ClyA of ''E. coli'' and reporter proteins such as Bla and GFP were translocated across the cytoplasmic membrane <sup>[[Team:Paris/Addressing_overview2#References|[3]]]</sup>.,<sup>[[Team:Paris/Addressing_overview2#References|[4]]]</sup>. and that localization was independent of the position (N or C terminus) of ClyA in the fusion protein. Moreover a recent article <sup>[[Team:Paris/Addressing_overview2#References|[5]]]</sup>. demonstrated that fusions to the C terminus of ClyA allow the transport of protein closer to the surface of outer membrane and to extend them into the extracellular environment. |
| + | <span/ id="6"> | ||
| + | ===OmpA=== | ||
| - | |||
| - | + | OmpA is a major protein of the outer membrane of ''E.Coli''. Moreover Kesty and co-workers demonstrated that OmpA is an outer-membrane component of native vesicles <sup>[[Team:Paris/Addressing_overview2#References|[6]]]</sup>.. In this direction, our strategy is to fuse our protein of interest to OmpA to allow its transport to the outer membrane and to increase the probability of its integration into vesicles. | |
| - | + | ||
| - | OmpA is a major protein of the outer membrane of ''E.Coli''. Moreover Kesty and co-workers demonstrated that OmpA is an outer-membrane component of native vesicles | + | |
We finally decided to focus our efforts on the ClyA strategy because of the previous work that was done on this protein especially the "proof" that it's possible to merge our protein of interest with ClyA without inhibiting both activities. | We finally decided to focus our efforts on the ClyA strategy because of the previous work that was done on this protein especially the "proof" that it's possible to merge our protein of interest with ClyA without inhibiting both activities. | ||
| Line 116: | Line 102: | ||
| - | + | ====References==== | |
| - | + | <ol class="references"> | |
| - | + | <li> [[Team:Paris/Addressing_overview2#1 | ^]] The structure of a cytolytic a-helical toxin pore reveals its assembly mechanism, M.Mueller & N.Ban. 2009 - [http://www.ncbi.nlm.nih.gov/pubmed/19421192 | 19421192 ]</li> | |
| - | + | <li> [[Team:Paris/Addressing_overview2#1 | ^]]S.N. Wai, B.Lindmark, T.Soderblom, A.Takade, M.Westermark, J.Oscarsson, et al. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin, 2003, Cell, 115, 25–35. [http://www.ncbi.nlm.nih.gov/pubmed/14532000 14532000]</li> | |
| - | + | <li> [[Team:Paris/Addressing_overview2#1 | ^]]F.J del Castillo, F. Moreno. and I.del Castillo. Secretion of the Escherichia coli K-12 SheA hemolysin is independent of its cytolytic activity, 2001, FEMS Microbiol.Lett. 204, 281–285. [http://www.ncbi.nlm.nih.gov/pubmed/11731136 11731136]</li> | |
| - | + | <li> [[Team:Paris/Addressing_overview2#1 | ^]]J.E.Galen, L.Zhao, M.Chinchilla, J.Y.Wang,M.F.Pasetti, J.Green and M.M. Levine. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA, 2004, Infect. Immun. 72, 7096–7106.[http://www.ncbi.nlm.nih.gov/pubmed/15557633 15557633]</li> | |
| - | + | <li> [[Team:Paris/Addressing_overview2#1 | ^]] J.Y. Kim, A.M. Doody, D. J. Chen, G.H. Cremona, M.L. Shuler, D.Putnam,and M.P. DeLisa.Engineered. Bacterial Outer Membrane Vesicles with Enhanced Functionality, 2008, J. Mol. Biol. 380, 51–66. [http://www.ncbi.nlm.nih.gov/pubmed/18511069 18511069]</li> | |
| - | + | <li> [[Team:Paris/Addressing_overview2#6 | ^]]N.C.Kesty, M.J.Kuehn. Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles, 2004, J Biol Chem. 279(3):2069-76.[http://www.ncbi.nlm.nih.gov/pubmed/14578354 14578354]</li> | |
| - | independent of its cytolytic activity, 2001, FEMS Microbiol.Lett. 204, 281–285. | + | </ol> |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | {{Template:Paris2009_guided|Addressing_overview| | + | {{Template:Paris2009_guided|Addressing_overview#Our_strategy|Addressing_overview3#bottom}} |
Latest revision as of 01:36, 22 October 2009
iGEM > Paris > Adressing > ClyA
Contents |
Addressing the message in the outer membrane : Main
Bacterial pathogens display proteins on their surface that may interact with their hosts in order to mount successful infections. Although the primary function of the peptidoglycan is to provide a physical barrier for protection against both mechanical and osmotic stresses, it also serves as a scaffold to anchor external structures such as the outer cell membrane in Escherichia Coli. Over the past 20 years, it has become apparent that Gram-negative bacteria have evolved a variety of mechanism by which proteins are displayed on the cell surface (Tat and Sec transporter for example, cf the section "to the periplasm, export system" for more information about them). Using these transport system, lot of protein are localized on the outer membrane, and one of the major protein of the bacterial membrane is OmpA. There is also an other protein, ClyA, but less known than OmpA which can be exported from cytoplasm to outer membrane, then by vesiculation interact with their host.
ClyA
Pore-forming toxins (PFTs) are a class of potent virulence factors that convert from a soluble form to a membrane-integrated pore. They exhibit their toxic effect either by destruction of the membrane permeability barrier or by delivery of toxic components through the pores.
Cytolysin A (ClyA, also known as HlyE), a PFT, is a cytolytic α-helical toxin responsible for the haemolytic phenotype of several E. coli. [1].
Why did we decided to use ClyA?
Althought the toxic effect of Cly A, using it is an interesting way to adress protein to the external membrane, because ClyA contain the signal peptide required to be exported form the cytoplasm to the outer membrane. In addition, it has been shown that certain membrane and/or soluble periplasmic proteins are enriched in vesicles while others are preferentially excluded. The majority of these enriched proteins happen to be virulence factors including cytolysin A of E. coli [2]..
Previous studies demonstrated that genetic fusions between ClyA of E. coli and reporter proteins such as Bla and GFP were translocated across the cytoplasmic membrane [3].,[4]. and that localization was independent of the position (N or C terminus) of ClyA in the fusion protein. Moreover a recent article [5]. demonstrated that fusions to the C terminus of ClyA allow the transport of protein closer to the surface of outer membrane and to extend them into the extracellular environment.
OmpA
OmpA is a major protein of the outer membrane of E.Coli. Moreover Kesty and co-workers demonstrated that OmpA is an outer-membrane component of native vesicles [6].. In this direction, our strategy is to fuse our protein of interest to OmpA to allow its transport to the outer membrane and to increase the probability of its integration into vesicles. We finally decided to focus our efforts on the ClyA strategy because of the previous work that was done on this protein especially the "proof" that it's possible to merge our protein of interest with ClyA without inhibiting both activities.
References
- ^ The structure of a cytolytic a-helical toxin pore reveals its assembly mechanism, M.Mueller & N.Ban. 2009 - [http://www.ncbi.nlm.nih.gov/pubmed/19421192 | 19421192 ]
- ^S.N. Wai, B.Lindmark, T.Soderblom, A.Takade, M.Westermark, J.Oscarsson, et al. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin, 2003, Cell, 115, 25–35. [http://www.ncbi.nlm.nih.gov/pubmed/14532000 14532000]
- ^F.J del Castillo, F. Moreno. and I.del Castillo. Secretion of the Escherichia coli K-12 SheA hemolysin is independent of its cytolytic activity, 2001, FEMS Microbiol.Lett. 204, 281–285. [http://www.ncbi.nlm.nih.gov/pubmed/11731136 11731136]
- ^J.E.Galen, L.Zhao, M.Chinchilla, J.Y.Wang,M.F.Pasetti, J.Green and M.M. Levine. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA, 2004, Infect. Immun. 72, 7096–7106.[http://www.ncbi.nlm.nih.gov/pubmed/15557633 15557633]
- ^ J.Y. Kim, A.M. Doody, D. J. Chen, G.H. Cremona, M.L. Shuler, D.Putnam,and M.P. DeLisa.Engineered. Bacterial Outer Membrane Vesicles with Enhanced Functionality, 2008, J. Mol. Biol. 380, 51–66. [http://www.ncbi.nlm.nih.gov/pubmed/18511069 18511069]
- ^N.C.Kesty, M.J.Kuehn. Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles, 2004, J Biol Chem. 279(3):2069-76.[http://www.ncbi.nlm.nih.gov/pubmed/14578354 14578354]
